In recent years, rates of catheter-associated bloodstream infections have dropped dramatically. In this issue's Inpatient Notes, the author discusses the interventions that may have brought about this improvement and suggests that the numbers may not be telling the whole story.
Ann Intern Med. 2017;167:845-854. Published 14 November 2017. doi:10.7326/M16-1157
This large retrospective study analyzed data from the U.S. Food and Drug Administration Sentinel Initiative, a national surveillance system, to compare rates of ischemic stroke, intracranial hemorrhage, extracranial bleeding, and myocardial infarction (MI) in patients taking warfarin or dabigatran. Investigators compared 25 289 patients starting warfarin with 25 289 propensity score-matched patients starting dabigatran for atrial fibrillation. The analysis revealed that patients treated with dabigatran had similar rates of ischemic stroke and extracranial bleeding as patients taking warfarin; however, they experienced less frequent intracranial bleeding (0.39 vs. 0.77 events per 100 person-years; hazard ratio, 0.51 [CI, 0.33 to 0.79]) but more frequent MI (0.77 vs. 0.43 events per 100 person-years; hazard ratio, 1.88 [CI, 1.22 to 2.90]).
Key points for hospitalists include:
Ann Intern Med. 2017;167:882-883. Published 21 November 2017. doi:10.7326/M17-2202
This Ideas and Opinions piece describes the electronic health record as a powerful tool in detecting harm from medical error that very few hospitals are using to its full potential. Most hospitals still rely on voluntary reporting to detect errors, but this is known to be an insensitive method for detecting harm. The authors suggest that emerging techniques should allow all hospitals to use their electronic health records to facilitate detection of harm from medical error.
Key points for hospitalists include:
Ann Intern Med. 2017;167:816-817. Published 24 October 2017. doi:10.7326/M17-1766
This Ideas and Opinions piece introduces the notion of creating an electronic patient portal for hospitalized patients. Electronic patient portals are frequently used in the outpatient arena and seem to engage patients in their own care. However, they have not been well-studied in the inpatient setting. These portals can allow hospitalized patients to see their own health records, including test results and medication administration records, a roster of the care team, and a daily care plan. They can also allow patients to save notes or questions and to communicate more directly and asynchronously with the care team. A small pilot study conducted by the authors showed that patients using an electronic portal had higher satisfaction scores than contemporaneous controls that did not have access to the portal.
Key points for hospitalists include:
Ann Intern Med. 2017;167:JC50. doi:10.7326/ACPJC-2017-167-10-050
This guideline is based on a systematic review of the literature examining studies that addressed perioperative management of antirheumatic medications. Although most of the included evidence was of low quality, recommendations from a panel of experts were almost unanimous in endorsing the following clinical practices: a) to continue perioperative home doses of glucocorticoids (as opposed to stress doses) during surgery; b) to continue nonbiologic disease–modifying antirheumatic drugs in the perioperative setting; and c), to avoid use or initiation of biologic agents in the perioperative period.
Ann Intern Med. 2017;167:JC59. doi:10.7326/ACPJC-2017-167-10-059
In this patient level meta-analysis, data from 4 prospective diagnosis and treatment trials (n = 6148) were analyzed and revealed that for patients with a Wells score >4 and negative CTPA, 2% had venous thromboembolism and 0.48% had fatal pulmonary embolism at 3 months. The findings suggest that although powerful, CTPA is an imperfect test. Thus, it may be useful to maintain a low threshold to reinvestigate patients with negative CTPA and a high clinical probability of disease if symptoms persist or worsen.